[go: up one dir, main page]

IL134760A0 - Method of increasing bone volume using non-naturally-occurring fp selective agonists - Google Patents

Method of increasing bone volume using non-naturally-occurring fp selective agonists

Info

Publication number
IL134760A0
IL134760A0 IL13476098A IL13476098A IL134760A0 IL 134760 A0 IL134760 A0 IL 134760A0 IL 13476098 A IL13476098 A IL 13476098A IL 13476098 A IL13476098 A IL 13476098A IL 134760 A0 IL134760 A0 IL 134760A0
Authority
IL
Israel
Prior art keywords
naturally
occurring
bone volume
increasing bone
selective agonists
Prior art date
Application number
IL13476098A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL134760A0 publication Critical patent/IL134760A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13476098A 1997-09-09 1998-09-04 Method of increasing bone volume using non-naturally-occurring fp selective agonists IL134760A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5830697P 1997-09-09 1997-09-09
PCT/US1998/018338 WO1999012551A1 (en) 1997-09-09 1998-09-04 Method of increasing bone volume using non-naturally-occurring fp selective agonists

Publications (1)

Publication Number Publication Date
IL134760A0 true IL134760A0 (en) 2001-04-30

Family

ID=22015996

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13476098A IL134760A0 (en) 1997-09-09 1998-09-04 Method of increasing bone volume using non-naturally-occurring fp selective agonists

Country Status (20)

Country Link
US (1) US6156799A (tr)
EP (1) EP1045694A1 (tr)
JP (1) JP2001515864A (tr)
KR (1) KR20010023840A (tr)
CN (1) CN1269721A (tr)
AR (1) AR013479A1 (tr)
AU (1) AU739275B2 (tr)
BR (1) BR9811780A (tr)
CA (1) CA2303800A1 (tr)
CO (1) CO4980882A1 (tr)
HU (1) HUP0004581A2 (tr)
ID (1) ID24827A (tr)
IL (1) IL134760A0 (tr)
NO (1) NO20001171L (tr)
PE (1) PE119099A1 (tr)
PL (1) PL339288A1 (tr)
SK (1) SK3412000A3 (tr)
TR (1) TR200000662T2 (tr)
WO (1) WO1999012551A1 (tr)
ZA (1) ZA988228B (tr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3711900A (en) * 1999-03-05 2000-09-21 Procter & Gamble Company, The Method of increasing bone volume using non-naturally-occurring ep1 selective agonists
WO2000051616A1 (en) * 1999-03-05 2000-09-08 The Procter & Gamble Company Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives
IL145122A0 (en) * 1999-03-05 2002-06-30 Procter & Gamble C16 unsaturated fp-selective prostaglandin analogs
JP2002538138A (ja) * 1999-03-05 2002-11-12 ザ プロクター アンド ギャンブル カンパニー Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体
CA2303060A1 (en) * 1999-04-14 2000-10-14 United States Gear Corporation Towed vehicle brake controller
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US7467892B2 (en) 2000-08-29 2008-12-23 Imaging Therapeutics, Inc. Calibration devices and methods of use thereof
AU2001286892B2 (en) 2000-08-29 2007-03-15 Imaging Therapeutics Inc. Methods and devices for quantitative analysis of x-ray images
US6904123B2 (en) 2000-08-29 2005-06-07 Imaging Therapeutics, Inc. Methods and devices for quantitative analysis of x-ray images
US8639009B2 (en) 2000-10-11 2014-01-28 Imatx, Inc. Methods and devices for evaluating and treating a bone condition based on x-ray image analysis
US7660453B2 (en) 2000-10-11 2010-02-09 Imaging Therapeutics, Inc. Methods and devices for analysis of x-ray images
CA2446296A1 (en) 2001-05-25 2002-12-05 Imaging Therapeutics, Inc. Methods to diagnose treat and prevent bone loss
ES2360604T3 (es) * 2001-07-23 2011-06-07 Ono Pharmaceutical Co., Ltd. Remedios para enfermedades con pérdida de masa osea que tienen como ingrediente activo agonistas de ep4.
KR20070043059A (ko) * 2001-07-23 2007-04-24 오노 야꾸힝 고교 가부시키가이샤 Ｅｐ４ 아고니스트를 유효 성분으로 하는 골량 저하 질환의치료제
US20060013851A1 (en) * 2002-02-07 2006-01-19 Giroux Karen J Therapeutic polyanhydride compounds for drug delivery
US8965075B2 (en) 2002-09-16 2015-02-24 Imatx, Inc. System and method for predicting future fractures
US7840247B2 (en) 2002-09-16 2010-11-23 Imatx, Inc. Methods of predicting musculoskeletal disease
US8600124B2 (en) 2004-09-16 2013-12-03 Imatx, Inc. System and method of predicting future fractures
CA2519187A1 (en) 2003-03-25 2004-10-14 Imaging Therapeutics, Inc. Methods for the compensation of imaging technique in the processing of radiographic images
EP1663002A4 (en) * 2003-09-19 2007-11-28 Imaging Therapeutics Inc BONE STRUCTURE PROGNOSTIC METHOD AND SIMULATED BONE REMODELING
US20080058613A1 (en) * 2003-09-19 2008-03-06 Imaging Therapeutics, Inc. Method and System for Providing Fracture/No Fracture Classification
US8290564B2 (en) 2003-09-19 2012-10-16 Imatx, Inc. Method for bone structure prognosis and simulated bone remodeling
US8939917B2 (en) 2009-02-13 2015-01-27 Imatx, Inc. Methods and devices for quantitative analysis of bone and cartilage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4621100A (en) * 1981-09-25 1986-11-04 The Upjohn Company Treatment of osteoporosis with prostaglandins
WO1993015767A1 (en) * 1992-02-05 1993-08-19 Merck & Co., Inc. Implant therapy for bone growth stimulation
US5310759A (en) * 1992-08-12 1994-05-10 Bockman Richard S Methods of protecting and preserving connective and support tissues
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
US5747660A (en) * 1995-11-06 1998-05-05 The University Of Colorado Nucleic acid encoding prostaglandin F2α receptor regulatory protein
US5703108A (en) * 1996-02-28 1997-12-30 Pfizer Inc. Bone deposition by certain prostaglandin agonists

Also Published As

Publication number Publication date
KR20010023840A (ko) 2001-03-26
EP1045694A1 (en) 2000-10-25
NO20001171L (no) 2000-05-09
US6156799A (en) 2000-12-05
JP2001515864A (ja) 2001-09-25
TR200000662T2 (tr) 2000-07-21
CO4980882A1 (es) 2000-11-27
ZA988228B (en) 1999-03-09
WO1999012551A1 (en) 1999-03-18
BR9811780A (pt) 2000-09-12
ID24827A (id) 2000-08-24
AU9219298A (en) 1999-03-29
AR013479A1 (es) 2000-12-27
AU739275B2 (en) 2001-10-11
HUP0004581A2 (hu) 2001-05-28
PE119099A1 (es) 2000-02-03
NO20001171D0 (no) 2000-03-07
CN1269721A (zh) 2000-10-11
SK3412000A3 (en) 2000-12-11
PL339288A1 (en) 2000-12-04
CA2303800A1 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
IL134760A0 (en) Method of increasing bone volume using non-naturally-occurring fp selective agonists
HUP0001811A3 (en) Bone paste and method for preparation thereof
ZA989272B (en) Method for making soft tissue
GB9826655D0 (en) System and method for sampling blood
PL329274A1 (en) Novel derivatives of isoquinolin-3-carboxylamides, method of obtaining them, their application, pharmaceutic agent containing them and method of obtaining such pharmaceutic agent
PL330841A1 (en) Benzosulphonic derivatives, method of obtaining them and therapeutic agents containing such derivatives
EP0977764A4 (en) PROCESS FOR PRODUCING SACCHARIDE FRAGMENTS
PL320132A1 (en) Analogues of vitamin d3, method of obtaining them and pharmaceutic compositions containing them
HUP0002062A3 (en) Method for diagnosing bone dysbolism
PL335074A1 (en) Method of obtaining eprosartane
PL335075A1 (en) Method of obtaining eprosartane
PL334901A1 (en) Method of obtaining benzothiazolones
PL339297A1 (en) Method of inctrasing bone volume
PL339188A1 (en) Method of obtaining oxaphosphorin-2-amines
NZ513828A (en) Method of increasing bone volume using non-naturally-occurring EP1 selective agonists
PL341358A1 (en) Method of obtaining paroxetin chlorhydride
PL336480A1 (en) Novel method of obtaining 3-n-,n-dicyclobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopirane-5-carboxamide
GB2374019B (en) Method for sampling blood
PL340915A1 (en) Method of obtaining azacycloalkylalkanoyl pseudotetrapeptides
NZ513827A (en) Methods of increasing bone volume using non-naturally-occurring FP selective agonists and antiresorptive compounds
PL321925A1 (en) Method of obtaining 1-(p-methoxybenzooyl)-2-pyrolydone
PL336266A1 (en) Method of obtaining epsilon-caprolactams
PL341302A1 (en) Method of obtaining chlorobenzoxazoles
GB9707760D0 (en) Fracture cell apparatus
PL336664A1 (en) Method of obtaining 1,1,1,3,3- pentachlorobutane